Bair Hugger surgical warming blanket lawsuit: how MDL 2666 was revived after 2019 dismissal and what the litigation looks like in 2026

The Bair Hugger forced-air warming blanket litigation represents one of the more procedurally complex active medical device mass torts, with procedural reversals through the appellate process that have affected the litigation's trajectory. MDL 2666 (In re: Bair Hugger Forced Air Warming Devices Products Liability Litigation), pending before Judge Joan N. Ericksen in the U.S. District Court for the District of Minnesota, has approximately 8,545 pending cases as of May 1, 2026, making it among the largest active MDLs in the federal system. The litigation has survived a 2019 mass dismissal when Judge Ericksen excluded plaintiff causation experts under Daubert v. Merrell Dow Pharmaceuticals, 509 U.S. 579 (1993) standards, with the Eighth Circuit reversing in 2021 holding that "weaknesses in expert testimony should go to weight, not admissibility" and the Supreme Court declining review in May 2023.

The theory centers on the Bair Hugger Forced Air Warming System, developed in 1987 by Dr. Scott Augustine and marketed through Augustine Medical, Inc., later acquired by 3M Company for approximately $810 million in 2010, used in 80-90% of U.S. hospital operating rooms with over 200 million patients warmed throughout its history. The device draws room air through a filter, heats it to up to 43°C (109.4°F), and blows it through a disposable perforated blanket placed on the patient. Plaintiffs allege the forced warm air disrupts the carefully controlled laminar airflow systems in modern operating rooms, engineered air ventilation systems that push clean, filtered air downward from the ceiling in a uniform curtain to flush bacteria away from the sterile surgical field. The plaintiffs' theory is that the rising warm air from the Bair Hugger interacts with the laminar flow and creates turbulent pockets near the surgical site, carrying bacteria from the operating room floor and equipment toward open surgical wounds during joint replacement procedures. The resulting deep joint infections, often involving MRSA, sepsis, or osteomyelitis, frequently require revision surgery, sometimes lead to amputation, and have resulted in deaths in severe cases.

The first federal bellwether trial (Shirley Hilke v. 3M) began January 21, 2026, with substantial implications for the litigation's framework. Earlier 3M won the first bellwether in May 2018 (Gareis v. 3M) and the February 2025 plaintiff win in Boncher v. 3M preserved expert testimony linking Bair Hugger to deep joint infections in the Eastern District of Pennsylvania, with 18 bellwether candidate cases remaining active after court-ordered dismissals for noncompliance. State court cases continue in parallel across Texas, Missouri, Minnesota, Pennsylvania, New Mexico, and Montana, with a $39.75 million state court verdict in 2023 providing benchmark valuation framework. 3M continues to defend the product's safety record without agreeing to global settlement framework, but the bellwether activity in 2026 should provide guidance for resolution framework.

This is how the Bair Hugger litigation actually works through MDL 2666 and parallel state court litigation, the theory of operating room airflow disruption, the procedural history through the 2019 dismissal and 2021 revival, the eligibility framework for current and prospective plaintiffs, and the strategic considerations for affected patients pursuing claims.

What is the Bair Hugger device and what defect do plaintiffs allege?

The Bair Hugger is a forced-air warming system used in 80-90% of U.S. operating rooms, heating air up to 43°C and blowing it through a disposable blanket onto surgical patients. Plaintiffs allege the rising warm air disrupts laminar airflow in operating rooms, creating turbulent pockets that carry bacteria from the floor toward open surgical wounds during joint replacement procedures.

Forced-air warming system. Used during surgery to:

• Prevent perioperative hypothermia (body temperature below 36°C/96.8°F)

• Maintain normothermia throughout surgical procedures

• Reduce infection risk (its intended effect)

• Hose connecting unit to blanket

• Disposable perforated blanket placed on patient

• Heats air up to 43°C (109.4°F)

• Forces warm air through blanket onto patient

• 80-90% of U.S. operating rooms

• 200+ million patients warmed since 1987

• Standard practice for many surgeries

• Medical benefit when functioning safely

Clinical guidelines support warming. Per CDC's 2017 SSI Prevention Guidelines and Cochrane Reviews:

Operating room laminar airflow systems. Modern surgical suites use:

• Filtered air pushed downward from ceiling

• Uniform curtain of clean air

• Flushes bacteria away from sterile surgical field

• Bair Hugger pumps warm air OUT from under blanket

• Warm air rises (basic physics)

• Rising warm air interacts with downward laminar flow

• Creates turbulent pockets near surgical site

• Carries bacteria from floor toward surgical wound

• Bacteria enter open joint or wound

• Floor (cleaning notwithstanding, bacterial load)

• Patient skin outside sterile field

• Implanted joint (hip, knee replacement) becomes infected

• Difficult to treat without removing implant

What injuries are alleged in Bair Hugger lawsuits?

Plaintiffs in MDL 2666 most commonly allege deep joint infections of the hip or knee following replacement surgery, often involving MRSA, sepsis, or osteomyelitis. These infections frequently require revision surgery, prolonged antibiotic treatment, and in severe cases lead to amputation or death. Chronic pain, permanent disability, and wrongful death claims are also asserted.

• Hip joint infections after hip replacement
• Knee joint infections after knee replacement
• Difficult to treat without surgery

What is the procedural history of Bair Hugger MDL 2666?

MDL 2666 was centralized in the District of Minnesota in December 2015, survived a 2019 mass dismissal when Judge Ericksen excluded plaintiffs' causation experts, and was revived by the Eighth Circuit in August 2021 (9 F.4th 768). The Supreme Court denied 3M's certiorari petition in May 2023. As of May 2026, the MDL holds approximately 8,545 pending cases with active bellwether trials underway.

2009-2010. 3M acquires Arizant Healthcare (Augustine Medical successor) for ~$810 million.

2010s. Increasing scientific concern about laminar flow disruption.

2013. First Bair Hugger lawsuit (Walton v. 3M) filed in Texas state court.

2015 (December). Judicial Panel on Multidistrict Litigation centralizes 60+ cases in MDL 2666 in District of Minnesota.

May 2018. First bellwether trial (Gareis v. 3M):

• "Dirty machine" evidence excluded pretrial
• Case proceeded on airflow disruption theory only

July 2019. Judge Ericksen excludes plaintiffs' general causation experts:

• Drs. Samet, Jarvis, Stonnington, Elghobashi excluded
• All remaining MDL cases dismissed via summary judgment

2020. Eighth Circuit upholds Ericksen's expert exclusion and dismissal:

August 2021. Eighth Circuit reverses, 9 F.4th 768 (8th Cir. 2021):

• "The standard for judging evidentiary reliability is lower than the merits standard of correctness"
• "Weaknesses in expert testimony should go to weight, not admissibility"

February 2022. Judge Ericksen appoints retired Magistrate Judge Arthur Boylan to mediate.

May 2023. Supreme Court denies 3M's certiorari petition.

December 2022. 3M sent letter to Judge Ericksen seeking to fast-track new bellwether trials.

February 2025. Boncher v. 3M plaintiff win:

• E.D. Pa. court denied 3M's motion for summary judgment
• Court denied 3M's attempt to exclude plaintiff experts
• Both general and specific causation experts met Rule 702 standards

January 21, 2026. First federal bellwether trial begins (Shirley Hilke v. 3M):

Current status (May 2026). 8,545 pending cases:

What is happening with Bair Hugger state court litigation?

Bair Hugger cases proceed in parallel in state courts across Texas, Missouri, Minnesota, Pennsylvania, New Mexico, and Montana. A $39.75 million Minnesota state court verdict in 2023 established a benchmark valuation. Some states apply lower evidentiary thresholds than federal Daubert standards, giving plaintiffs procedural advantages, with multiple state court trial dates extending through 2026.

Active state court cases as of January 2025:

• Some states have lower Daubert-equivalent standards
• Procedural advantage in some states

Who is eligible to file a Bair Hugger lawsuit?

Eligibility requires documented use of a Bair Hugger warming device during surgery (verified through operative reports or anesthesia records) followed by a deep joint infection, typically within 60 days. Plaintiffs must show bacterial culture results, treatment records including revision surgery, and must file within the applicable state statute of limitations, which generally runs two to four years from injury or discovery.

Documenting Bair Hugger use

Critical first step. Verify Bair Hugger was used:

state-by-state variation. Most states 2-4 years from injury or discovery:

• Specific state law analysis required
• Some delayed discovery cases viable

How does the Bair Hugger litigation compare to other medical device mass torts?

The Bair Hugger MDL is distinctive for its 2019 dismissal and 2021 Eighth Circuit revival, its 8,545 pending cases with no global settlement, and its active 2026 bellwether trial program. Unlike peer MDLs such as Stryker ($1.4B settlement) or Bard hernia mesh ($1B+ settlement), 3M has not agreed to any global resolution framework despite its financial capacity.

• Active bellwether trials (Hilke January 2026)
• $39.75 million verdict benchmark
• 80-90% market penetration of warming devices
• Scientific complexity (operating room airflow)

What are the projected Bair Hugger lawsuit settlement amounts?

A $39.75 million Minnesota state court verdict in 2023 provides a benchmark.

Bellwether outcomes will substantially affect framework. First federal bellwether (Hilke) began January 21, 2026. Subsequent outcomes will substantially affect:

State court verdict benchmark: $39.75 million Minnesota verdict (2023) provides framework.

Tax implications. Personal injury settlements for physical injuries are tax-free under IRC §104(a)(2). Coordinate with tax counsel for settlements, particularly when other tax debt issues or §72(t) early withdrawal considerations exist.

What strategic considerations should Bair Hugger plaintiffs know?

Plaintiffs should first verify Bair Hugger use through operative and anesthesia records, then comprehensively document the infection with bacterial culture results and revision surgery records. Filing within the applicable statute of limitations (typically two to four years) is critical. Engaging counsel experienced in MDL practice and monitoring bellwether outcomes will help maximize recovery potential.

Verify Bair Hugger use first. Critical first step:

Address the statute of limitations carefully. 3M defenses:

• 2-4 year periods in most states
• Some delayed discovery cases viable

Consider state court alternatives. parallel state court action:

• Texas, Missouri, Minnesota, Pennsylvania, New Mexico, Montana
• Potentially better outcomes for some plaintiffs
• Different evidentiary standards in some states

Coordinate with treating physicians. Orthopedic surgeons, infectious disease specialists, and other treating physicians are important witnesses.

Plan for the growth loss when accessing retirement funds. Some plaintiffs:

• Need retirement funds for medical expenses
• §72(t) early withdrawal cost
• May benefit from medical expense exception

Address related tax planning. Personal injury settlements for physical injuries are tax-free. Component allocation (physical injury vs. emotional distress) affects tax treatment.

Watch the wrongful death framework. Some severe cases:

• Loss of function post-infection
• Inability to return to work

Don't accept inadequate settlement offers without thorough evaluation. Many cases:

• Injury justifies more than initial offers

• Negotiate based on documented damages

• Consider individual trial if settlement insufficient

• May proceed to individual MDL trial

• May proceed to remand for individual state court trial

Address the ongoing Bair Hugger use issue. Substantial:

Coordinate with LLC asset protection if business assets at risk.

• 2021 8th Circuit ruling precedent
• 2025 Boncher EDPA win framework

For affected patients with documented Bair Hugger-related joint infections, the litigation provides paths to compensation through the MDL 2666 framework, the parallel state court litigation, and the active bellwether trial program that began January 21, 2026 with Shirley Hilke v. 3M. The procedural history, particularly the 2019 mass dismissal and 2021 Eighth Circuit revival, has shaped the litigation but the cases that remain are substantially stronger after the procedural pruning of noncompliant cases throughout 2025-2026. The work for plaintiffs is in comprehensive verification of Bair Hugger use through hospital records, thorough infection documentation including bacterial culture results and revision surgery records, engagement with experienced Bair Hugger counsel familiar with MDL practice and the statute of limitations issues, coordination of medical and legal timelines, informed monitoring of bellwether and settlement developments, and patient navigation of the procedural complexity. For plaintiffs with strong documented cases, particularly those involving severe complications, multiple revision surgeries, or wrongful death situations, the litigation provides paths to meaningful compensation that should produce outcomes through the 3M financial capacity, the developing bellwether framework, and the state court parallel verdicts providing benchmark valuation framework for the pending and future case inventory.